The evaluation of a successful home hemodialysis program: establishing a prospective framework for quality.
A mounting body of clinical data and purported quality of life benefits has been primarily responsible for a renewed interest in programs providing longer more frequent home hemodialysis. As novel forms of home hemodialysis (HHD) like nocturnal (nightly) home hemodialysis (NHD) move from strictly the academic "experimental" arenas to potentially the preferred renal replacement modality for patients, it will be necessary for programs to plan and evaluate standardized metrics for program quality. This will be essential for smaller, less experienced centers to gauge their outcomes against larger, more established programs. Driven by market forces primarily in the United States, conventional hemodialysis programs have begun to explore optimal strategies for reporting quality of care in their respective dialysis centers. Extrapolating this to home hemodialysis modalities the question remains which criteria do we use as measures of quality? The evidence is limited to small, observational studies and one small randomized controlled trial. Extrapolating existing quality indices from conventional hemodialysis seems reasonable however may miss many of the true clinically significant advantages of HHD as a modality. Although definitive evidence does not yet exist for intensive home hemodialysis strategies, clearly clinicians, payers and patients are convinced enough of this approach for programs to justify the expansion of these modalities. We have laid the groundwork for the CANadian Slow Long nightly ExtEnded dialysis Programs (CAN-SLEEP), a multicenter cohort aimed to investigate the clinical and programmatic outcomes of NHD. This will allow for the assessment of numerous outcomes on a global scale for this state-of-the art dialysis modality in the form of a multidimensional programmatic evaluation.
Komenda
P
P
Department of Medicine, Section of Nephrology, St Boniface General Hospital, University of Manitoba, Manitoba Renal Program, Winnipeg, MB, Canada. paulkomenda@yahoo.com
Chan
C
C
Pauly
R P
RP
Levin
A
A
Copland
M
M
Pierratos
A
A
Sood
M M
MM
D019985:Benchmarking / Q000379:methods*; D002170:Canada; D006437:Hemodialysis, Home / Q000191:economics / Q000379:methods / Q000592:standards; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D011446:Prospective Studies; D011785:Quality Assurance, Health Care / Q000458:organization & administration*